Assignee profile:

NOBELPHARMA CO., LTD.

City:

Tokyo

Country:

Japan

Published Applications:

13

Last publication date:

2026-05-21

Patent Grants:

9

Last grant date:

2022-12-06

Top Inventors for applications by NOBELPHARMA CO., LTD.

These are the the leading inventors for applications assigned to NOBELPHARMA CO., LTD.:

Recent patent applications by NOBELPHARMA CO., LTD.

NOBELPHARMA CO., LTD. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-21
US20260137664A1
Human necessities

THERAPEUTIC AGENT FOR INTRACTABLE LYMPHATIC DISEASE AND INTRACTABLE VASCULAR DISEASE

#2 | 2026-01-01
US20260000707A1
Human necessities

Tablet with improved stability

#3 | 2023-09-21
US20230293510A1
Human necessities

PATCH FOR ALLEVIATING OR TREATING SYMPTOMS OF NEURODEGENERATIVE DISEASE

#4 | 2022-05-26
US20220160697A1
Human necessities

PHARMACEUTICAL COMPOSITION HAVING EXCELLENT DRUG ABSORPTION INTO THE LIVING BODY AND EXCELLENT CHEMICAL STABILITY

#5 | 2020-10-22 ✅ Patent 11,517,424 granted on 2022-12-06
US20200330219A1
Human necessities

Tool for molding dysphonia treatment tool, and method for bending front piece of dysphonia treatment tool

#6 | 2019-12-26 ✅ Patent 11,001,557 granted on 2021-05-11
US20190389803A1
Chemistry; metallurgy

Antiviral drug for severe fever with thrombocytopenia syndrome

#7 | 2019-10-31 ✅ Patent 11,523,908 granted on 2022-12-13
US20190328531A1
Human necessities

Dysphonia treatment tool

#8 | 2019-02-07 ✅ Patent 10,357,595 granted on 2019-07-23
US20190038811A1
Human necessities

Agent for regenerating tympanic membrane or external auditory canal

#9 | 2019-01-24 ✅ Patent 10,369,159 granted on 2019-08-06
US20190022111A1
Human necessities

Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using same

#10 | 2018-10-04 ✅ Patent 11,051,985 granted on 2021-07-06
US20180280198A1
Human necessities

Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agent

#11 | 2018-08-16 ✅ Patent 10,813,765 granted on 2020-10-27
US20180228611A1
Human necessities

Voice disorder treatment tool and voice disorder treatment set

#12 | 2016-03-10 ✅ Patent 10,117,969 granted on 2018-11-06
US20160067383A1
Human necessities

Agent for regenerating tympanic membrane or external auditory canal

#13 | 2011-05-12 ✅ Patent 9,161,904 granted on 2015-10-20
US20110110987A1
Human necessities

Agent for regenerating tympanic membrane or external auditory canal

Also check out NOBELPHARMA CO., LTD.'s (Tokyo, Japan) applicant profile with 11 patent applications submitted.

AssigneeID:

144965 ⎘